 | • レポートコード：MRC2012B1142 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、組換えタンパク質の世界市場を広く調査・分析し、今後の市場展望をまとめております。組換えタンパク質の種類別市場規模（ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント阻害剤、その他）、用途別市場規模（バイオ医薬品産業、学術研究機関、委託研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abcam PLC、Merck KGaA、Thermo Fisher Scientific、R&D Systems、Lonza、Miltenyi Biotec、Eurogentec (Kaneka Corporation)、GE Healthcare、Sigma Aldrich Company、ProSpec Tany TechnoGene、Abnova Corporation、PeproTech、GenScript Biotech Corporation、BPS Bioscience、Reprocell、 ・地域別グローバル市場分析 2015年-2020年 ・組換えタンパク質の北米市場（アメリカ、カナダ、メキシコ） ・組換えタンパク質のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・組換えタンパク質のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・組換えタンパク質の南米市場（ブラジル、アルゼンチン） ・組換えタンパク質の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ホルモン、成長因子、サイトカイン、血漿タンパク質因子、組換え代謝酵素、免疫チェックポイント阻害剤、その他 ・用途別分析：バイオ医薬品産業、学術研究機関、委託研究機関 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Recombinant Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Recombinant Proteins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 848.9 million by 2025, from USD 629.7 million in 2019.
Market segmentation
Recombinant Proteins market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Recombinant Proteins market has been segmented into:
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application, Recombinant Proteins has been segmented into:
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Recombinant Proteins market presented in the report. This section sheds light on the sales growth of different regional and country-level Recombinant Proteins markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Recombinant Proteins market.
The report offers in-depth assessment of the growth and other aspects of the Recombinant Proteins market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Recombinant Proteins Market Share Analysis
Recombinant Proteins competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Recombinant Proteins sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Recombinant Proteins sales, revenue and market share for each player covered in this report.
The major players covered in Recombinant Proteins are:
Abcam PLC
Merck KGaA
Thermo Fisher Scientific
R&D Systems
Lonza
Miltenyi Biotec
Eurogentec (Kaneka Corporation)
GE Healthcare
Sigma Aldrich Company
ProSpec Tany TechnoGene
Abnova Corporation
PeproTech
GenScript Biotech Corporation
BPS Bioscience
Reprocell
Among other players domestic and global, Recombinant Proteins market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Recombinant Proteins Market Overview
1.1 Product Overview and Scope of Recombinant Proteins
1.2 Classification of Recombinant Proteins by Type
1.2.1 Global Recombinant Proteins Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Recombinant Proteins Revenue Market Share by Type in 2019
1.2.3 Hormones
1.2.4 Growth Factors
1.2.5 Cytokines
1.2.6 Plasma Protein Factor
1.2.7 Recombinant Metabolic Enzymes
1.2.8 Immune Checkpoint Regulators
1.2.9 Others
1.3 Global Recombinant Proteins Market by Application
1.3.1 Overview: Global Recombinant Proteins Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Global Recombinant Proteins Market by Regions
1.4.1 Global Recombinant Proteins Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Recombinant Proteins (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Recombinant Proteins Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Recombinant Proteins Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Recombinant Proteins Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Recombinant Proteins Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Recombinant Proteins Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abcam PLC
2.1.1 Abcam PLC Details
2.1.2 Abcam PLC Major Business
2.1.3 Abcam PLC SWOT Analysis
2.1.4 Abcam PLC Product and Services
2.1.5 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA SWOT Analysis
2.2.4 Merck KGaA Product and Services
2.2.5 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific SWOT Analysis
2.3.4 Thermo Fisher Scientific Product and Services
2.3.5 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.4 R&D Systems
2.4.1 R&D Systems Details
2.4.2 R&D Systems Major Business
2.4.3 R&D Systems SWOT Analysis
2.4.4 R&D Systems Product and Services
2.4.5 R&D Systems Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza SWOT Analysis
2.5.4 Lonza Product and Services
2.5.5 Lonza Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.6 Miltenyi Biotec
2.6.1 Miltenyi Biotec Details
2.6.2 Miltenyi Biotec Major Business
2.6.3 Miltenyi Biotec Product and Services
2.6.4 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eurogentec (Kaneka Corporation)
2.7.1 Eurogentec (Kaneka Corporation) Details
2.7.2 Eurogentec (Kaneka Corporation) Major Business
2.7.3 Eurogentec (Kaneka Corporation) Product and Services
2.7.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Product and Services
2.8.4 GE Healthcare Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sigma Aldrich Company
2.9.1 Sigma Aldrich Company Details
2.9.2 Sigma Aldrich Company Major Business
2.9.3 Sigma Aldrich Company Product and Services
2.9.4 Sigma Aldrich Company Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.10 ProSpec Tany TechnoGene
2.10.1 ProSpec Tany TechnoGene Details
2.10.2 ProSpec Tany TechnoGene Major Business
2.10.3 ProSpec Tany TechnoGene Product and Services
2.10.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.11 Abnova Corporation
2.11.1 Abnova Corporation Details
2.11.2 Abnova Corporation Major Business
2.11.3 Abnova Corporation Product and Services
2.11.4 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.12 PeproTech
2.12.1 PeproTech Details
2.12.2 PeproTech Major Business
2.12.3 PeproTech Product and Services
2.12.4 PeproTech Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.13 GenScript Biotech Corporation
2.13.1 GenScript Biotech Corporation Details
2.13.2 GenScript Biotech Corporation Major Business
2.13.3 GenScript Biotech Corporation Product and Services
2.13.4 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.14 BPS Bioscience
2.14.1 BPS Bioscience Details
2.14.2 BPS Bioscience Major Business
2.14.3 BPS Bioscience Product and Services
2.14.4 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
2.15 Reprocell
2.15.1 Reprocell Details
2.15.2 Reprocell Major Business
2.15.3 Reprocell Product and Services
2.15.4 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Recombinant Proteins Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Recombinant Proteins Players Market Share
3.2.2 Top 10 Recombinant Proteins Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Recombinant Proteins Revenue and Market Share by Regions
4.2 North America Recombinant Proteins Revenue and Growth Rate (2015-2020)
4.3 Europe Recombinant Proteins Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Recombinant Proteins Revenue and Growth Rate (2015-2020)
4.5 South America Recombinant Proteins Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Recombinant Proteins Revenue and Growth Rate (2015-2020)
5 North America Recombinant Proteins Revenue by Countries
5.1 North America Recombinant Proteins Revenue by Countries (2015-2020)
5.2 USA Recombinant Proteins Revenue and Growth Rate (2015-2020)
5.3 Canada Recombinant Proteins Revenue and Growth Rate (2015-2020)
5.4 Mexico Recombinant Proteins Revenue and Growth Rate (2015-2020)
6 Europe Recombinant Proteins Revenue by Countries
6.1 Europe Recombinant Proteins Revenue by Countries (2015-2020)
6.2 Germany Recombinant Proteins Revenue and Growth Rate (2015-2020)
6.3 UK Recombinant Proteins Revenue and Growth Rate (2015-2020)
6.4 France Recombinant Proteins Revenue and Growth Rate (2015-2020)
6.5 Russia Recombinant Proteins Revenue and Growth Rate (2015-2020)
6.6 Italy Recombinant Proteins Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Recombinant Proteins Revenue by Countries
7.1 Asia-Pacific Recombinant Proteins Revenue by Countries (2015-2020)
7.2 China Recombinant Proteins Revenue and Growth Rate (2015-2020)
7.3 Japan Recombinant Proteins Revenue and Growth Rate (2015-2020)
7.4 Korea Recombinant Proteins Revenue and Growth Rate (2015-2020)
7.5 India Recombinant Proteins Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Recombinant Proteins Revenue and Growth Rate (2015-2020)
8 South America Recombinant Proteins Revenue by Countries
8.1 South America Recombinant Proteins Revenue by Countries (2015-2020)
8.2 Brazil Recombinant Proteins Revenue and Growth Rate (2015-2020)
8.3 Argentina Recombinant Proteins Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Recombinant Proteins by Countries
9.1 Middle East & Africa Recombinant Proteins Revenue by Countries (2015-2020)
9.2 Saudi Arabia Recombinant Proteins Revenue and Growth Rate (2015-2020)
9.3 UAE Recombinant Proteins Revenue and Growth Rate (2015-2020)
9.4 Egypt Recombinant Proteins Revenue and Growth Rate (2015-2020)
9.5 South Africa Recombinant Proteins Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Recombinant Proteins Revenue and Market Share by Type (2015-2020)
10.2 Global Recombinant Proteins Market Forecast by Type (2019-2024)
10.3 Hormones Revenue Growth Rate (2015-2025)
10.4 Growth Factors Revenue Growth Rate (2015-2025)
10.5 Cytokines Revenue Growth Rate (2015-2025)
10.6 Plasma Protein Factor Revenue Growth Rate (2015-2025)
10.7 Recombinant Metabolic Enzymes Revenue Growth Rate (2015-2025)
10.8 Immune Checkpoint Regulators Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Recombinant Proteins Market Segment by Application
11.1 Global Recombinant Proteins Revenue Market Share by Application (2015-2020)
11.2 Recombinant Proteins Market Forecast by Application (2019-2024)
11.3 Biopharmaceutical Companies Revenue Growth (2015-2020)
11.4 Academic and Research Institutes Revenue Growth (2015-2020)
11.5 Contract Research Organizations Revenue Growth (2015-2020)
12 Global Recombinant Proteins Market Size Forecast (2021-2025)
12.1 Global Recombinant Proteins Market Size Forecast (2021-2025)
12.2 Global Recombinant Proteins Market Forecast by Regions (2021-2025)
12.3 North America Recombinant Proteins Revenue Market Forecast (2021-2025)
12.4 Europe Recombinant Proteins Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Recombinant Proteins Revenue Market Forecast (2021-2025)
12.6 South America Recombinant Proteins Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Recombinant Proteins Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Recombinant Proteins Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Recombinant Proteins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Recombinant Proteins Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Recombinant Proteins Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Recombinant Proteins Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abcam PLC Corporate Information, Location and Competitors
Table 7. Abcam PLC Recombinant Proteins Major Business
Table 8. Abcam PLC Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 9. Abcam PLC SWOT Analysis
Table 10. Abcam PLC Recombinant Proteins Product and Solutions
Table 11. Abcam PLC Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Merck KGaA Corporate Information, Location and Competitors
Table 13. Merck KGaA Recombinant Proteins Major Business
Table 14. Merck KGaA Recombinant Proteins Total Revenue (USD Million) (2018-2019)
Table 15. Merck KGaA SWOT Analysis
Table 16. Merck KGaA Recombinant Proteins Product and Solutions
Table 17. Merck KGaA Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 19. Thermo Fisher Scientific Recombinant Proteins Major Business
Table 20. Thermo Fisher Scientific Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 21. Thermo Fisher Scientific SWOT Analysis
Table 22. Thermo Fisher Scientific Recombinant Proteins Product and Solutions
Table 23. Thermo Fisher Scientific Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. R&D Systems Corporate Information, Location and Competitors
Table 25. R&D Systems Recombinant Proteins Major Business
Table 26. R&D Systems Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 27. R&D Systems SWOT Analysis
Table 28. R&D Systems Recombinant Proteins Product and Solutions
Table 29. R&D Systems Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Lonza Corporate Information, Location and Competitors
Table 31. Lonza Recombinant Proteins Major Business
Table 32. Lonza Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 33. Lonza SWOT Analysis
Table 34. Lonza Recombinant Proteins Product and Solutions
Table 35. Lonza Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Miltenyi Biotec Corporate Information, Location and Competitors
Table 37. Miltenyi Biotec Recombinant Proteins Major Business
Table 38. Miltenyi Biotec Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 39. Miltenyi Biotec SWOT Analysis
Table 40. Miltenyi Biotec Recombinant Proteins Product and Solutions
Table 41. Miltenyi Biotec Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Eurogentec (Kaneka Corporation) Corporate Information, Location and Competitors
Table 43. Eurogentec (Kaneka Corporation) Recombinant Proteins Major Business
Table 44. Eurogentec (Kaneka Corporation) Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 45. Eurogentec (Kaneka Corporation) SWOT Analysis
Table 46. Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions
Table 47. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. GE Healthcare Corporate Information, Location and Competitors
Table 49. GE Healthcare Recombinant Proteins Major Business
Table 50. GE Healthcare Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 51. GE Healthcare SWOT Analysis
Table 52. GE Healthcare Recombinant Proteins Product and Solutions
Table 53. GE Healthcare Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Sigma Aldrich Company Corporate Information, Location and Competitors
Table 55. Sigma Aldrich Company Recombinant Proteins Major Business
Table 56. Sigma Aldrich Company Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 57. Sigma Aldrich Company SWOT Analysis
Table 58. Sigma Aldrich Company Recombinant Proteins Product and Solutions
Table 59. Sigma Aldrich Company Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. ProSpec Tany TechnoGene Corporate Information, Location and Competitors
Table 61. ProSpec Tany TechnoGene Recombinant Proteins Major Business
Table 62. ProSpec Tany TechnoGene Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 63. ProSpec Tany TechnoGene SWOT Analysis
Table 64. ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions
Table 65. ProSpec Tany TechnoGene Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Abnova Corporation Corporate Information, Location and Competitors
Table 67. Abnova Corporation Recombinant Proteins Major Business
Table 68. Abnova Corporation Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 69. Abnova Corporation SWOT Analysis
Table 70. Abnova Corporation Recombinant Proteins Product and Solutions
Table 71. Abnova Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. PeproTech Corporate Information, Location and Competitors
Table 73. PeproTech Recombinant Proteins Major Business
Table 74. PeproTech Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 75. PeproTech SWOT Analysis
Table 76. PeproTech Recombinant Proteins Product and Solutions
Table 77. PeproTech Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. GenScript Biotech Corporation Corporate Information, Location and Competitors
Table 79. GenScript Biotech Corporation Recombinant Proteins Major Business
Table 80. GenScript Biotech Corporation Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 81. GenScript Biotech Corporation SWOT Analysis
Table 82. GenScript Biotech Corporation Recombinant Proteins Product and Solutions
Table 83. GenScript Biotech Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. BPS Bioscience Corporate Information, Location and Competitors
Table 85. BPS Bioscience Recombinant Proteins Major Business
Table 86. BPS Bioscience Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 87. BPS Bioscience SWOT Analysis
Table 88. BPS Bioscience Recombinant Proteins Product and Solutions
Table 89. BPS Bioscience Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Reprocell Corporate Information, Location and Competitors
Table 91. Reprocell Recombinant Proteins Major Business
Table 92. Reprocell Recombinant Proteins Total Revenue (USD Million) (2017-2018)
Table 93. Reprocell SWOT Analysis
Table 94. Reprocell Recombinant Proteins Product and Solutions
Table 95. Reprocell Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Recombinant Proteins Revenue (Million USD) by Players (2015-2020)
Table 97. Global Recombinant Proteins Revenue Share by Players (2015-2020)
Table 98. Global Recombinant Proteins Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Recombinant Proteins Revenue Market Share by Regions (2015-2020)
Table 100. North America Recombinant Proteins Revenue by Countries (2015-2020)
Table 101. North America Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Table 102. Europe Recombinant Proteins Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Recombinant Proteins Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Recombinant Proteins Revenue by Countries (2015-2020)
Table 105. South America Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Recombinant Proteins Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Table 108. Global Recombinant Proteins Revenue (Million USD) by Type (2015-2020)
Table 109. Global Recombinant Proteins Revenue Share by Type (2015-2020)
Table 110. Global Recombinant Proteins Revenue Forecast by Type (2021-2025)
Table 111. Global Recombinant Proteins Revenue by Application (2015-2020)
Table 112. Global Recombinant Proteins Revenue Share by Application (2015-2020)
Table 113. Global Recombinant Proteins Revenue Forecast by Application (2021-2025)
Table 114. Global Recombinant Proteins Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Recombinant Proteins Picture
Figure 2. Global Recombinant Proteins Revenue Market Share by Type in 2019
Figure 3. Hormones Picture
Figure 4. Growth Factors Picture
Figure 5. Cytokines Picture
Figure 6. Plasma Protein Factor Picture
Figure 7. Recombinant Metabolic Enzymes Picture
Figure 8. Immune Checkpoint Regulators Picture
Figure 9. Others Picture
Figure 10. Recombinant Proteins Revenue Market Share by Application in 2019
Figure 11. Biopharmaceutical Companies Picture
Figure 12. Academic and Research Institutes Picture
Figure 13. Contract Research Organizations Picture
Figure 14. Global Recombinant Proteins Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Recombinant Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Recombinant Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Recombinant Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Recombinant Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Recombinant Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Recombinant Proteins Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Recombinant Proteins Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Recombinant Proteins Revenue Market Share in 2019
Figure 23. Global Top 10 Players Recombinant Proteins Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Recombinant Proteins Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Recombinant Proteins Revenue Market Share by Regions (2015-2020)
Figure 27. Global Recombinant Proteins Revenue Market Share by Regions in 2018
Figure 28. North America Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 29. Europe Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 31. South America Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 33. North America Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Figure 34. North America Recombinant Proteins Revenue Market Share by Countries in 2019
Figure 35. USA Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 36. Canada Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 38. Europe Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Recombinant Proteins Revenue Market Share by Countries in 2019
Figure 40. Germany Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 41. UK Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 42. France Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 43. Russia Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 44. Italy Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Recombinant Proteins Revenue Market Share by Countries in 2019
Figure 47. China Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 48. Japan Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 49. Korea Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 50. India Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 52. South America Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Figure 53. South America Recombinant Proteins Revenue Market Share by Countries in 2019
Figure 54. Brazil Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Recombinant Proteins Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Recombinant Proteins Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 59. UAE Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Recombinant Proteins Revenue and Growth Rate (2015-2020)
Figure 62. Global Recombinant Proteins Revenue Share by Type (2015-2020)
Figure 63. Global Recombinant Proteins Revenue Share by Type in 2019
Figure 64. Global Recombinant Proteins Market Share Forecast by Type (2021-2025)
Figure 65. Global Hormones Revenue Growth Rate (2015-2020)
Figure 66. Global Growth Factors Revenue Growth Rate (2015-2020)
Figure 67. Global Cytokines Revenue Growth Rate (2015-2020)
Figure 68. Global Plasma Protein Factor Revenue Growth Rate (2015-2020)
Figure 69. Global Recombinant Metabolic Enzymes Revenue Growth Rate (2015-2020)
Figure 70. Global Immune Checkpoint Regulators Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Recombinant Proteins Revenue Share by Application (2015-2020)
Figure 73. Global Recombinant Proteins Revenue Share by Application in 2019
Figure 74. Global Recombinant Proteins Market Share Forecast by Application (2021-2025)
Figure 75. Global Biopharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 76. Global Academic and Research Institutes Revenue Growth Rate (2015-2020)
Figure 77. Global Contract Research Organizations Revenue Growth Rate (2015-2020)
Figure 78. Global Recombinant Proteins Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Recombinant Proteins Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Recombinant Proteins Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Recombinant Proteins Revenue Market Forecast (2021-2025)
Figure 82. Europe Recombinant Proteins Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Recombinant Proteins Revenue Market Forecast (2021-2025)
Figure 84. South America Recombinant Proteins Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Recombinant Proteins Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- 組換えヒトタンパク質の世界市場（～2026年） Recombinant proteins are used throughout biological and biomedical science. Their production was once the domain of experts, but the development of simple, commercially available systems has made the technology more widespread. Market Analysis and Insights: Global Recombinant Human Proteins Market T…
- 組換え非グリコシル化タンパク質バイオシミラーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Non-Glycosylated Proteins Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.…
- 組換えタンパク質の世界市場（～2026年） Market Analysis and Insights: Global Recombinant Protein Market The global Recombinant Protein market size is projected to reach US$ 665.5 million by 2026, from US$ 612 million in 2020, at a CAGR of 8.1%% during 2021-2026. Global Recombinant Protein Scope and Market Size Recombinant Protein market i…
- 血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…